The upregulation in tumors and in the adjacent tissue may serve different purposes, as was suggested for IL32, the overexpression of which in gastrointestinal tumors reflected proliferative and metastatic potential, and antiapoptotic and immunosuppressive capacity in non-transformed mucosa [58]. Here, IL32 is linked to digestive system neoplasm.